Pulse Biosciences, Inc Common Stock (DE) Canaccord Genuity's 46th Annual Growth Conference

Thank you, Bill. Thank you.

Sure. So I got into med tech in 1980. I was a summer intern for Kendall, which became part of Medtronic, and they hired me before I even went back to my second year of business school. So I was 23 and working in marketing in med tech. I stayed there for 4 years and then made an important move for me, which was to go to C. R. Bard. Bard, at that time, was launching the first interventional cardiology platform in the world with the first coronary angioplasty system. So I became part of that, ultimately ran that business. Stayed at Bard for 9 years. Became President of Cardiology across, foretelling, the electrophysiology peripheral vascular and coronary vascular space. I then joined a company, at that time, I had never heard of in Boston called Boston Scientific. It was a $200 million company at the time.

I joined as the President of International. Went on to run groups of divisions across the med surge group, the endosurgery business, if you will, President of Cardiology, Group President of Cardiovascular, Chief Operating Officer over all business units, all operations, and that spanned 15 years and moved the company up to $8 billion. That was then 30 years in aggregate experience, and I retired at that point, 2008. Became a venture capitalist, started to invest in med tech companies, and joined some boards, both public and private, as an independent director. Spent the last 18 years doing that and sold a lot of companies, made a lot of investments, and have some lasting boards, including companies like Edwards Lifesciences. I was contacted by Pulse in 2024, looking to add an experienced med tech veteran, if you will, to the board.

Really just in an interaction with Bob Duggan, one thing led to another. He asked me to join the board, I did, and almost immediately flipped into the CEO role. So it's been a fantastic process. I will say I did diligence as a VC would in Pulse and started to look at the technology, look at the markets, and we can talk more about it, but I found in it something that I thought was absolutely exceptional. So I tell folks that the board asked me to join as CEO in a car leaving the parking lot on the way to dinner. I said "Yes" on the spot. Then I told my wife after that. So don't take marital advice from me, but I was so convinced about the technology that I didn't need to think twice about the opportunity.

Bob is an impressive human, and his track record in business is matched, frankly, by his track record in other non-business activities. He is a remarkable person. I met Bob in this process. I did not know of Bob. I knew of his work. I knew of his building of Computer Motion and the merging of Computer Motion with Intuitive Surgical. He was then on the board of Intuitive for a decade after that.